UK'S MHRA: SOTATERCEPT APPROVED TO TREAT ADULT PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION (PAH)
Further company coverage: MRK.N
((Reuters.Briefs@thomsonreuters.com;))
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.